Public Availability of Labeling Changes in "Changes Being Effected" Supplements
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 20, 2006
May 15, 2020
0cd869a7-e345-4545-b817-9cde8e7c7438
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Alcoholism: Developing Drugs for Treatment
Guidance DocumentFebruary 12, 2015Center for Drug Evaluation and Research
How To Obtain a Covered Product Authorization
Guidance DocumentSeptember 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox